Gujarat Themis Biosyn zooms 14% on acquiring Sanofi's TB drug portfolio

The buying on the counter came after Gujarat Themis Biosyn signed an Asset Purchase Agreement with Sanofi to acquire a portfolio of 13 established branded generic anti TB products

Go to News Site